Up and Coming Glaucoma Procedures: Almost Ready for Prime Time | ASCRS
Satellite CME Programs

Up and Coming Glaucoma Procedures

Up and Coming Glaucoma Procedures: Almost Ready for Prime Time

Friday, May 5, 4:00 – 5:00 PM PST 

Join moderators Leon Herndon, MD and Nathan Radcliffe, MD as they and expert faculty discuss the new and emerging options in glaucoma procedures and treatments. 



Program Chairs

Leon Herndon

Leon W. Herndon, MD

Nathan Radcliffe, MD

Invited Faculty

Rosa Braga-Mele, MD, FRCSC

Cathleen McCabe, MD

Rob Noecker, MD, MBA

Sarah Van Tassel, MD

May 05, 2023

4:00 – 4:02 pm
Welcome Remarks

Leon Herndon, MD, and Nathan Radcliffe, MD

4:03 – 4:12 pm
Eagle DSTL

Sarah Van Tassel, MD

4:13 – 4:22 pm
Elios Technology

Rosa Braga-Mele, MD, FRCSC

4:23 – 4:32 pm

Rob Noecker, MD, MBA

4:56 – 5:00 pm
Closing Remarks

Leon Herndon, MD, and Nathan Radcliffe, MD

CME Mission Statement

ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.

Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates the Up and Coming Glaucoma Procedures: Almost ready for prime time for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Objectives:

  • Describe and compare new and emerging options in glaucoma procedures.
  • Differentiate between the current and upcoming approaches to glaucoma treatment.


Disclosure of Financial Interest
All faculty members are required to disclose whether they, or their spouses, have any financial interest (or lack thereof) from the past 24 months with a company that produces, markets, resells or distribute ophthalmic products or services consumed by, or used on, patients. Faculty members are also required to disclose such information verbally and on their first slide.

ASCRS considers presenting authors, no co-authors, to be in control of the educational content. As a professional courtesy, ASCRS acknowledges co-authors and all people contributing to the research, regardless of CME control of the live presentation of that content. Though they are acknowledged, co-authors do not have control of the CME content and their disclosures are not published or resolved.

Presenter Disclosures
It is an ASCRS requirement that all presenters disclose on the first slide and verbally at the beginning of any presentation whether they have any relevant financial interests from the past 24 months. Presenters are expected to give a fair and balanced presentation.

Notice About Off-Label Use Presentations

The program may include presentations on drugs or devices, or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wished to use in clinical practice.

ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.